Opportunity ID: 337854

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-111
Funding Opportunity Title: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 04, 2022
Last Updated Date: Feb 04, 2022
Original Closing Date for Applications: Jan 07, 2025
Current Closing Date for Applications: Jan 07, 2025
Archive Date: Feb 12, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
State governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Small businesses
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-111.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00271946 Jun 14, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or before January 24, 2025 PKG00277802 Nov 01, 2022 Jan 24, 2025 View

Package 1

Mandatory forms

337854 RR_SF424_5_0-5.0.pdf

337854 PHS398_CoverPageSupplement_5_0-5.0.pdf

337854 RR_OtherProjectInfo_1_4-1.4.pdf

337854 PerformanceSite_4_0-4.0.pdf

337854 RR_KeyPersonExpanded_4_0-4.0.pdf

337854 PHS398_ResearchPlan_4_0-4.0.pdf

337854 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337854 RR_Budget_3_0-3.0.pdf

337854 RR_SubawardBudget30_3_0-3.0.pdf

337854 PHS398_ModularBudget_1_2-1.2.pdf

337854 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

337854 RR_SF424_5_0-5.0.pdf

337854 PHS398_CoverPageSupplement_5_0-5.0.pdf

337854 RR_OtherProjectInfo_1_4-1.4.pdf

337854 PerformanceSite_4_0-4.0.pdf

337854 RR_KeyPersonExpanded_4_0-4.0.pdf

337854 PHS398_ResearchPlan_5_0-5.0.pdf

337854 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337854 RR_Budget_3_0-3.0.pdf

337854 RR_SubawardBudget30_3_0-3.0.pdf

337854 PHS398_ModularBudget_1_2-1.2.pdf

337854 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T12:11:23-05:00

Share This Post, Choose Your Platform!

About the Author: